Education
About Us
Working with TipRanks
Follow Us
AngioDynamics (ANGO)
NASDAQ:ANGO
ANGO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$5.83 - $13.50
Previous CloseN/A
Volume2.49M
Average Volume (3M)669.96K
Market Cap
$393.34M
Enterprise Value$366.09M
Total Cash (Recent Filing)$55.89M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.28
Next Earnings
Oct 02, 2025EPS Estimate
-0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding40,633,884
10 Day Avg. Volume357,888
30 Day Avg. Volume669,963
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.93
Enterprise Value/Revenue1.25
Enterprise Value/Gross Profit2.48
Enterprise Value/Ebitda-44.47
Forecast
1Y Price Target
$19.00Price Target Upside94.08% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAngioDynamics reported a beat on both top- and bottom-line results for FY25, indicating strong performance.
Market PotentialANGO's stock is undervalued for the access to multiple high-growth markets it already has, along with the potential further upside from its ability to enter both DVT and coronary markets in the future.
Product GrowthMed Tech segment demonstrated significant growth, with notable increases in sales of key products like Auryon, AngioVac, and AlphaVac.
Bears Say
Competitive RisksRisks include lower-than-projected growth of Med Tech revenue and higher-than-expected competition.
Market MaturityANGO should see continued growth in Auryon, but likely more moderated comparatively over the long term given atherectomy is a mature market.
Product ConcernsLow sequential growth of the company’s AlphaVac product was noted as a concern, as more growth was expected given it is still an early product in a growing market.
AngioDynamics News
ANGO FAQ
What was AngioDynamics’s price range in the past 12 months?
AngioDynamics lowest stock price was $5.83 and its highest was $13.50 in the past 12 months.
What is AngioDynamics’s market cap?
AngioDynamics’s market cap is $393.34M.
When is AngioDynamics’s upcoming earnings report date?
AngioDynamics’s upcoming earnings report date is Oct 02, 2025 which is in 36 days.
How were AngioDynamics’s earnings last quarter?
AngioDynamics released its earnings results on Jul 15, 2025. The company reported -$0.03 earnings per share for the quarter, beating the consensus estimate of -$0.119 by $0.089.
Is AngioDynamics overvalued?
According to Wall Street analysts AngioDynamics’s price is currently Undervalued.
Does AngioDynamics pay dividends?
AngioDynamics does not currently pay dividends.
What is AngioDynamics’s EPS estimate?
AngioDynamics’s EPS estimate is -0.12.
How many shares outstanding does AngioDynamics have?
AngioDynamics has 40,633,884 shares outstanding.
What happened to AngioDynamics’s price movement after its last earnings report?
AngioDynamics reported an EPS of -$0.03 in its last earnings report, beating expectations of -$0.119. Following the earnings report the stock price went down -10.177%.
Which hedge fund is a major shareholder of AngioDynamics?
Currently, no hedge funds are holding shares in ANGO
AngioDynamics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$19.00 (94.08% Upside)
$19.00 (94.08% Upside)
Blogger Sentiment
Bullish
ANGO Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 133.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▲ 0.9%
Last 30 Days ▼ 2.5%
Last 30 Days ▼ 2.5%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
26.04%
12-Months-Change
Fundamentals
Return on Equity
-17.50%
Trailing 12-Months
Asset Growth
-11.81%
Trailing 12-Months
Company Description
AngioDynamics
AngioDynamics, Inc. is a leading provider of innovative medical devices used for the minimally invasive treatment of cancer and peripheral vascular disease. The company operates primarily in the healthcare sector, specializing in the development, manufacture, and sale of medical, surgical, and diagnostic devices that advance the care of patients by enhancing the quality of healthcare. Its core products include radiofrequency ablation systems, laser systems, vascular access products, and fluid management systems, catering to a diverse range of healthcare providers across the globe.
ANGO Company Deck
ANGO Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented strong revenue growth and strategic progress, particularly in the MedTech segment and international expansion. Despite challenges such as tariff impacts and a decrease in NanoKnife capital sales, the company demonstrated positive financial performance and a robust future growth outlook.View all ANGO earnings summariesANGO Stock 12 Month Forecast
Average Price Target
$19.00
▲(94.08% Upside)
Technical Analysis
Ownership Overview
5.39% Insiders
16.48% Mutual Funds
39.54% Other Institutional Investors
26.43% Public Companies and
Individual Investors